세계의 경구 피임약 시장은 2024년에 342억 1,000만 달러로 평가되었고, 예측 기간 동안 연평균 성장률(CAGR)은 6.76%를 나타낼 것으로 예측되며, 2030년에는 506억 4,000만 달러에 이를 것으로 전망됩니다.
경구 피임약(출산 조절 약물)은 임신을 방지하고 출산율을 조절하기 위해 특별히 고안된 약물입니다. 이 약물은 에스트로겐과 프로게스틴이라는 두 가지 여성 호르몬을 조합하여 합성으로 제조됩니다. 이 호르몬들은 배란을 효과적으로 억제함으로써 난소에서 난자가 방출되는 것을 막는 데 핵심적인 역할을 합니다. 경구 피임약은 배란을 방지할 뿐만 아니라 자궁경부 점액을 두껍게 만들어 정자가 난자에 도달하여 수정하기 어렵게 만듭니다. 또한 자궁 내막을 변화시켜 수정란 착상에 불리한 환경을 조성합니다. 이러한 핵심 작용 기전을 표적으로 삼음으로써 경구 피임약은 매우 효과적인 피임 수단을 제공합니다. 원치 않는 임신 예방이라는 주요 목적 외에도 경구 피임약은 여러 추가 혜택을 제공합니다. 여드름, 골다공증, 난소암 등 특정 암의 위험을 감소시키는 것으로 밝혀졌습니다. 또한 난관 및 자궁 감염 예방에 도움을 주고, 월경 전 증후군(PMS) 증상을 완화시킬 수 있습니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2026-2030년 |
| 시장 규모 : 2024년 | 342억 1,000만 달러 |
| 시장 규모 : 2030년 | 506억 4,000만 달러 |
| 연평균 성장률(CAGR)(2025-2030년) | 6.76% |
| 급성장 부문 | 복합 경구 피임약 |
| 최대 시장 | 북미 |
여성의 생식 건강에 미치는 중대한 영향을 고려하여 경구 피임약은 일반적으로 의료 전문가에 의해 처방 및 관리됩니다. 이 약물은 경구용 알약, 주사제, 국소 제형 등 다양한 형태로 제공되어 여성들이 개인의 필요와 선호도에 따라 선택할 수 있는 폭넓은 옵션을 제공합니다. 의학 연구 및 기술의 지속적인 발전에 따라 경구 피임약 분야는 계속 진화하여 여성들에게 더 많은 선택권과 계획되지 않은 임신 예방 효과를 제공하고 있습니다.
인구 통제 프로그램 증가
높은 기기 및 치료 비용
비호르몬 대체제
Global Contraceptive Pills Market has valued at USD 34.21 Billion in 2024 and is expected to reach USD 50.64 Billion by 2030 with a CAGR of 6.76% during the forecast period. Contraceptive pills, also known as birth control medications, are specifically designed to prevent pregnancy and regulate birth rates. These medications are synthetically formulated using a combination of two female hormones, estrogen and progestin. By effectively inhibiting ovulation, these hormones play a crucial role in preventing the release of eggs from the ovaries. Contraceptive pills not only prevent ovulation but also thicken the cervical mucus, making it more difficult for sperm to reach the egg for fertilization. Additionally, they can alter the lining of the womb, creating an environment that is unfavorable for the implantation of a fertilized egg. By targeting these key mechanisms, contraceptive pills provide a highly effective means of birth control. In addition to their primary purpose of preventing unwanted pregnancies, contraceptive pills offer several other benefits. They have been found to reduce the risks of acne, bone thinning, and certain types of cancers, such as ovarian cancer. Moreover, they can help prevent infections in the fallopian tubes and uterus, as well as alleviate symptoms of premenstrual syndrome (PMS).
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 34.21 Billion |
| Market Size 2030 | USD 50.64 Billion |
| CAGR 2025-2030 | 6.76% |
| Fastest Growing Segment | Combination Pills |
| Largest Market | North America |
Given their significant impact on women's reproductive health, contraceptive pills are typically prescribed and administered by healthcare practitioners. These medications are available in various forms, including oral pills, injectables, and topical formulations, providing women with a range of options to choose from based on their individual needs and preferences. With ongoing advancements in medical research and technology, the field of contraceptive pills continues to evolve, offering women more choices and improved effectiveness in preventing unplanned pregnancies. According to the State of World Population 2022 report by UNFPA, the United Nations sexual and reproductive health agency, nearly 121 million pregnancies globally each year-almost half of the total-are unintended.
Key Market Drivers
Increase in Population Control Program
The efforts made by governments to reduce population growth in various nations are not only raising women's understanding of family planning and contraception, but also bringing about significant changes in both urban and rural settings. In industrialized markets, the use of oral contraceptives has witnessed a substantial increase due to the rising occurrence of unintended pregnancies, prompting individuals to take proactive measures for contraception. As the population continues to expand at a rapid rate, particularly in Asian countries, the micro-level impact on the socio-economic balance becomes more evident. Recognizing the urgency of the situation, public and private players are joining hands to effectively manage the population growth, with a vision of bringing about a positive transformation in sex education and contraception use in the years to come. It is anticipated that these collaborative efforts will not only drive the market CAGR for contraceptive pills but also result in an overall improvement in healthcare outcomes. Thus, the revenue from the contraceptive pills market is predicted to experience a steady increase throughout the forecast period, reflecting the growing importance of addressing population growth and advancing reproductive health worldwide. For instance, in July 2023, the Karnataka Health Department in India introduced two new contraceptive methods for women as part of the National Family Planning Programme. The sub-dermal implant and subcutaneous injection were introduced in government-run health centers to promote reproductive and sexual health by increasing the gap between two births.
Key Market Challenges
High Cost of Devices and Treatment
The high cost of devices and treatment options is having a notable impact on the demand for contraceptive pills, creating financial barriers that hinder access for many individuals and couples. This trend reflects a complex interplay of economic factors that are shaping choices in reproductive healthcare. One of the primary reasons for the decreasing demand for contraceptive pills is the substantial upfront cost associated with alternative contraceptive methods. Devices such as intrauterine devices (IUDs) or contraceptive implants, while highly effective, often require a significant initial investment for insertion or implantation. This cost can be prohibitive for individuals without adequate insurance coverage or financial resources, causing them to opt for less expensive alternatives, including contraceptive pills.
Furthermore, ongoing maintenance and follow-up costs for certain contraceptive devices can add to the financial burden. For example, IUDs may require periodic check-ups or replacements, incurring additional expenses over time. In contrast, contraceptive pills have the advantage of a more predictable and manageable monthly cost, making them a more financially accessible option for many.
In addition to device costs, the expense of medical consultations and treatments associated with certain contraceptive methods can dissuade individuals from pursuing those options. Procedures like sterilization or permanent contraception can be costly and may not be covered by insurance, making them inaccessible for those with limited financial means. As a result, contraceptive pills, which are available with a prescription but typically require fewer medical interventions, remain a more affordable choice for many.
However, it's important to note that the declining demand for contraceptive pills due to high device and treatment costs is not uniform across all populations. In some cases, individuals and couples who can afford the upfront costs of more effective devices may choose them over contraceptive pills, leading to variations in contraceptive choices based on economic status. The high cost of contraceptive devices and associated treatments is indeed reducing the demand for contraceptive pills, particularly among individuals and couples with limited financial resources. While contraceptive pills offer an affordable and accessible option, addressing the financial barriers to alternative methods is crucial to ensuring equitable access to a wide range of contraceptive choices for all individuals, regardless of their economic circumstances.
Key Market Trends
Non-Hormonal Alternative
Growing concerns about hormonal side effects may lead to increased demand for non-hormonal contraceptive pills. Innovations in this area might include non-hormonal oral contraceptives or alternative delivery methods. Growing concerns about hormonal side effects associated with traditional contraceptive pills are indeed driving an increased demand for non-hormonal contraceptive options. This trend reflects a growing desire among individuals to have contraceptive choices that minimize hormonal interventions and their potential side effects. Research and development efforts are focused on creating non-hormonal oral contraceptive pills that are effective at preventing pregnancy without altering hormonal balances. These may include pills containing novel active ingredients that target fertility mechanisms without affecting hormones.
Advancements in drug delivery technology may lead to alternative methods of delivering non-hormonal contraceptives, such as patches, gels, or vaginal rings. Innovations in emergency contraception may offer non-hormonal alternatives for preventing pregnancy after unprotected intercourse, providing more options to those who wish to avoid hormonal interventions.
In this report, the Global Contraceptive Pills Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Contraceptive Pills Market.
Global Contraceptive Pills market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: